Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma
1998

Serum Hepatocyte Growth Factor in Colorectal Cancer Patients

Sample size: 60 publication Evidence: moderate

Author Information

Author(s): T Fukuura, C Miki, T Inoue, K Matsumoto, H Suzuki

Primary Institution: Mie University Medical School

Hypothesis

The study aims to evaluate the relationship between serum HGF concentration and clinicopathological parameters in patients with colorectal cancer.

Conclusion

Serum HGF concentration reflects the disease status and general preoperative condition of patients with colorectal carcinoma.

Supporting Evidence

  • The serum HGF concentration was significantly higher in cancer patients compared to normal controls.
  • HGF levels correlated with tumor size and metastasis.
  • Postoperative HGF levels decreased significantly after tumor resection.

Takeaway

Doctors measured a substance called HGF in the blood of cancer patients to see how it relates to their disease and health. Higher levels of HGF might mean more serious cancer.

Methodology

The study measured serum and tissue concentrations of HGF in 60 colorectal cancer patients and correlated these with various clinical parameters.

Participant Demographics

The mean age of participants was 64.7 years, with 31 males and no patients having abnormal liver function tests.

Statistical Information

P-Value

0.0003

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication